|
|
Volumn 363, Issue 2, 2015, Pages
|
|
A bacteriophage journey at the European medicines agency
a
a
a
a
a
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIRETROVIRUS AGENT;
INFLUENZA VACCINE;
ANTIINFECTIVE AGENT;
AVIAN INFLUENZA;
BACTERIAL INFECTION;
BACTERIOPHAGE;
EBOLA HEMORRHAGIC FEVER;
EUROPEAN MEDICINES AGENCY;
EXPERIMENTAL THERAPY;
HEALTH CARE ACCESS;
HEALTH CARE AVAILABILITY;
HEALTH CARE DISPARITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NOTE;
PRIORITY JOURNAL;
VIROTHERAPY;
ANTIBIOTIC RESISTANCE;
BACTERIAL INFECTIONS;
BACTERIUM;
BIOLOGICAL THERAPY;
DRUG EFFECTS;
EUROPE;
GENETICS;
MICROBIOLOGY;
PHYSIOLOGY;
VIROLOGY;
ANTI-BACTERIAL AGENTS;
BACTERIA;
BACTERIAL INFECTIONS;
BACTERIOPHAGES;
BIOLOGICAL THERAPY;
DRUG RESISTANCE, BACTERIAL;
EUROPE;
HUMANS;
|
|
EID: 84960115036
PISSN: 03781097
EISSN: 15746968
Source Type: Journal
DOI: 10.1093/femsle/fnv225 Document Type: Note |
|
Times cited : (59)
|
|
References (7)
|
